Tranquilnite
Natural health product licensed in Canada
- Licence holder
- New Chapter Inc
- NPN or DIN-HM
- 80007921
- Status
- Inactive licence
- Licence date
- 3 October 2008
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Passiflora incarnata Source : Fleur Extraction ratio : 8:1 Dry plant equivalent : 80 mg | 10 mg | Not calculated |
| Ziziphus jujube Source : Fruit(s) Extraction ratio : 5:1 Dry plant equivalent : 300 mg | 60 mg | Not calculated |
| Zingiber officinale Source : Rhizome(s) Extraction ratio : 18.5:1 Dry plant equivalent : 185 mg | 10 mg | Not calculated |
| Humulus lupulus Source : Strobiles Extraction ratio : 4.2:1 Dry plant equivalent : 126 mg | 30 mg | Not calculated |
| Zingiber officinale Source : Rhizome(s) Extraction ratio : 5:1 Dry plant equivalent : 50 mg | 10 mg | Not calculated |
Non-medicinal ingredients
huile d'olive, Carob, Maltodextrine, Glycérine végétale, Gélatine, Eau purifiée, Cire d'abeille jaune
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
Uses authorised in Canada
Helps to promote sleep and provides temporary relief from restlessness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Consult a health care practitioner if symptoms persist or worsen. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Exercise caution if operating heavy machinery or driving a motor vehicle within 2 hours of consumption. Consult a health care practitioner if you have gallbladder or bile-duct obstruction, hiatal hernia, acid reflex. Consult a health care practitioner prior to use if you are taking barbiturates, sedative drugs and/or other herbs with sedative properties. Consult a health care practitioner prior to use if you have depression and/or related diseases.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80007921
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.